Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bacillus cereus (1 trial)
bifidobacterium animalis (1 trial)
budesonide (rhinocort) (1 trial)
eltrombopag (promacta) (1 trial)
enterococcus faecium (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Lactobacillus acidophilus (1 trial)
thrombopoietin (1 trial)
bat5906 (1 trial)
borneol (1 trial)
dexamethasone (1 trial)
docetaxel (taxotere) (1 trial)
letrozole (femara) (1 trial)
nedaplatin (2 trials)
polygeline (1 trial)
pomalidomide (pomalyst) (1 trial)
ranibizumab (lucentis) (1 trial)
sodium chloride (1 trial)
urea (1 trial)
Filgrastim (neupogen) (1 trial)
nimotuzumab (1 trial)
paclitaxel (taxol) (1 trial)
sargramostim (leukine) (1 trial)
Telitacicept (1 trial)
azathioprine (imuran) (1 trial)
dehydroepiandrosterone (1 trial)
dextrose (1 trial)
leflunomide (arava) (1 trial)
linaclotide (linzess) (1 trial)
polyethylene glycol (1 trial)
Esophageal Neoplasms (Phase 2)
Neutropenia (Phase 2)
Ovarian Hyperstimulation Syndrome (Phase 3)
Syndrome (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Trials (15 total)
Trial APIs (30 total)